Published in J Biol Chem on June 10, 1978
Microinjection of catalytic subunit of cyclic AMP-dependent protein kinase enhances calcium action potentials of bag cell neurons in cell culture. Proc Natl Acad Sci U S A (1980) 2.84
Intracellular injection of t he catalytic subunit of cyclic AMP-dependent protein kinase simulates facilitation of transmitter release underlying behavioral sensitization in Aplysia. Proc Natl Acad Sci U S A (1980) 2.24
Synthesis of catalase in two cell-free protein-synthesizing systems and in rat liver. Proc Natl Acad Sci U S A (1978) 2.19
Rapid and reversible translocation of the catalytic subunit of cAMP-dependent protein kinase type II from the Golgi complex to the nucleus. EMBO J (1985) 2.02
Identification of an inhibitory region of the heat-stable protein inhibitor of the cAMP-dependent protein kinase. Proc Natl Acad Sci U S A (1985) 1.94
Calcium/calmodulin-dependent protein kinase II. Biochem J (1989) 1.78
Mutations in the catalytic subunit of cAMP-dependent protein kinase result in unregulated biological activity. Proc Natl Acad Sci U S A (1992) 1.75
Subunits of purified calcium channels: a 212-kDa form of alpha 1 and partial amino acid sequence of a phosphorylation site of an independent beta subunit. Proc Natl Acad Sci U S A (1989) 1.74
Adenosine 3',5'-phosphate in fungi. Microbiol Rev (1981) 1.62
Primary structure of the regulatory subunit of type II cAMP-dependent protein kinase from bovine cardiac muscle. Proc Natl Acad Sci U S A (1982) 1.58
The cAMP-binding domains of the regulatory subunit of cAMP-dependent protein kinase and the catabolite gene activator protein are homologous. Proc Natl Acad Sci U S A (1982) 1.43
The molecular cloning of a type II regulatory subunit of the cAMP-dependent protein kinase from rat skeletal muscle and mouse brain. Proc Natl Acad Sci U S A (1987) 1.42
A mechanistic and kinetic analysis of the interactions of the diastereoisomers of adenosine 3',5'-(cyclic)phosphorothioate with purified cyclic AMP-dependent protein kinase. Biochem J (1988) 1.42
Heterogeneous distribution of the cAMP receptor protein RII in the nervous system: evidence for its intracellular accumulation on microtubules, microtubule-organizing centers, and in the area of the Golgi complex. J Cell Biol (1986) 1.41
Activation of purified calcium channels by stoichiometric protein phosphorylation. Proc Natl Acad Sci U S A (1989) 1.38
Association of catalytic and regulatory subunits of cyclic AMP-dependent protein kinase requires a negatively charged side group at a conserved threonine. Mol Cell Biol (1990) 1.31
High-affinity binding of the regulatory subunit (RII) of cAMP-dependent protein kinase to microtubule-associated and other cellular proteins. Proc Natl Acad Sci U S A (1984) 1.30
Isolation of a cDNA clone for the type I regulatory subunit of bovine cAMP-dependent protein kinase. Proc Natl Acad Sci U S A (1983) 1.26
Role of PKA in the timing of developmental events in Dictyostelium cells. Microbiol Mol Biol Rev (1998) 1.20
Autophosphorylation: a salient feature of protein kinases. Mol Cell Biochem (1993) 1.11
Dibutyryl cAMP treatment of neuroblastoma-glioma hybrid cells results in selective increase in cAMP-receptor protein (R-I) as measured by monospecific antibodies. EMBO J (1983) 1.10
A cAMP-dependent protein kinase is present in differentiating Dictyostelium discoideum cells. EMBO J (1982) 1.08
Identification of a high affinity binding protein for the regulatory subunit RII beta of cAMP-dependent protein kinase in Golgi enriched membranes of human lymphoblasts. EMBO J (1992) 1.03
A small novel A-kinase anchoring protein (AKAP) that localizes specifically protein kinase A-regulatory subunit I (PKA-RI) to the plasma membrane. J Biol Chem (2012) 1.02
Chemical tools selectively target components of the PKA system. BMC Chem Biol (2009) 1.00
Use of a synthetic dodecapeptide (malantide) to measure the cyclic AMP-dependent protein kinase activity ratio in a variety of tissues. Biochem J (1990) 1.00
Phosphodiesterases catalyze hydrolysis of cAMP-bound to regulatory subunit of protein kinase A and mediate signal termination. Mol Cell Proteomics (2010) 0.99
Presence of free cyclic AMP receptor protein and regulation of its level by cyclic AMP in neuroblastoma-glioma hybrid cells. Proc Natl Acad Sci U S A (1979) 0.99
Active site coupling in PDE:PKA complexes promotes resetting of mammalian cAMP signaling. Biophys J (2014) 0.98
Localization of nuclear subunits of cyclic AMP-dependent protein kinase by the immunocolloidal gold method. J Cell Biol (1985) 0.95
Structural studies on a family of cAMP-binding proteins in the nervous system of Aplysia. J Cell Biol (1986) 0.95
Degradative inactivation of cyclic AMP-dependent protein kinase by a membranal proteinase is restricted to the free catalytic subunit in its native conformation. Proc Natl Acad Sci U S A (1981) 0.92
Cell-type specific expression of a dominant negative PKA mutation in mice. PLoS One (2011) 0.91
A-kinase anchoring proteins: a key to selective activation of cAMP-responsive events? Mol Cell Biochem (1993) 0.89
A constitutively active holoenzyme form of the cAMP-dependent protein kinase. Proc Natl Acad Sci U S A (1991) 0.89
Mode of stimulation by injection of cyclic AMP and external acidification of the sodium efflux in barnacle muscle fibres. J Physiol (1979) 0.87
c-ABL tyrosine kinase activity is regulated by association with a novel SH3-domain-binding protein. Mol Cell Biol (1996) 0.84
Platelet stimulation releases a cAMP-dependent protein kinase that specifically phosphorylates a plasma protein. Proc Natl Acad Sci U S A (1988) 0.84
Serotonin induces selective cleavage of the PKA RI subunit but not RII subunit in Aplysia neurons. Biochem Biophys Res Commun (2007) 0.83
Therapeutic strategies for anchored kinases and phosphatases: exploiting short linear motifs and intrinsic disorder. Front Pharmacol (2015) 0.83
Inhibition of adenosine 3',5'-monophosphate-dependent protein kinase by staphylococcal alpha-toxin. Infect Immun (1979) 0.82
Protein kinase A catalytic subunit isoform PRKACA; History, function and physiology. Gene (2015) 0.81
The testis-specific Cα2 subunit of PKA is kinetically indistinguishable from the common Cα1 subunit of PKA. BMC Biochem (2011) 0.80
T cell receptor induced intracellular redistribution of type I protein kinase A. Immunology (2004) 0.80
Epidermal growth factor receptor levels are reduced in mice with targeted disruption of the protein kinase A catalytic subunit. BMC Cell Biol (2008) 0.79
Sites of phosphorylation and mutation in regulatory subunit of cyclic AMP-dependent protein kinase from S49 mouse lymphoma cells: mapping to structural domains. J Cell Biol (1983) 0.79
PRKACB is downregulated in non-small cell lung cancer and exogenous PRKACB inhibits proliferation and invasion of LTEP-A2 cells. Oncol Lett (2013) 0.79
Expression, purification, characterization, and deletion mutations of phosphorylase kinase gamma subunit: identification of an inhibitory domain in the gamma subunit. Mol Cell Biochem (1993) 0.79
Targeting protein-protein interactions in complexes organized by A kinase anchoring proteins. Front Pharmacol (2015) 0.77
A study of the interaction between bovine cardiac-muscle cyclic AMP-dependent protein kinase and cyclic AMP using fluorescence-polarization spectroscopy. Biochem J (1984) 0.75
Reconstitution of rods from tobacco mosaic virus protein and RNA modified with bulky carcinogens. Proc Natl Acad Sci U S A (1982) 0.75
The unexpected evolution of basic science studies about cyclic nucleotide action into a treatment for erectile dysfunction. J Biol Chem (2014) 0.75
Protein Kinase A Subunit Balance Regulates Lipid Metabolism in Caenorhabditis elegans and Mammalian Adipocytes. J Biol Chem (2016) 0.75
Phosphorylation of the regulatory subunit of yeast cAMP-dependent protein kinase. Proc Natl Acad Sci U S A (1982) 0.75
Fine-structure mapping of charge-shift mutations in regulatory subunit of type I cyclic AMP-dependent protein kinase. Mol Cell Biol (1984) 0.75
Cyclic AMP-dependent protein kinases and cAMP-binding proteins in human mammary tumor MCF-7 cells. Arch Gynecol (1984) 0.75
Characterization of cyclic GMP-binding sites of cyclic GMP-dependent protein kinase by rapid filtration assay. Biochem J (1988) 0.75
The Lens Opacities Classification System III. The Longitudinal Study of Cataract Study Group. Arch Ophthalmol (1993) 9.69
BACE1 is the major beta-secretase for generation of Abeta peptides by neurons. Nat Neurosci (2001) 4.54
Lens opacities classification system II (LOCS II) Arch Ophthalmol (1989) 4.17
Assay of cyclic AMP-dependent protein kinases. Methods Enzymol (1974) 3.84
Public disclosure of health care performance reports: experience, evidence and issues for policy. Int J Qual Health Care (1999) 2.98
Regulation of myosin phosphatase by a specific interaction with cGMP- dependent protein kinase Ialpha. Science (1999) 2.84
The distribution and dissociation of cyclic adenosine 3':5'-monophosphate-dependent protein kinases in adipose, cardiac, and other tissues. J Biol Chem (1975) 2.84
Compartmentalization of adenosine 3':5'-monophosphate and adenosine 3':5'-monophosphate-dependent protein kinase in heart tissue. J Biol Chem (1977) 2.80
Signal probability, reinforcement and signal detection. J Exp Anal Behav (1979) 2.45
Cyclic nucleotide phosphodiesterases: relating structure and function. Prog Nucleic Acid Res Mol Biol (2001) 2.30
Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro. Am J Cardiol (1999) 2.25
A cyclic AMP--stimulated protein kinase in adipose tissue. Biochem Biophys Res Commun (1969) 2.21
Structure and function of cyclic nucleotide-dependent protein kinases. Annu Rev Physiol (1994) 2.20
Regulatory mechanisms in the control of protein kinases. CRC Crit Rev Biochem (1982) 2.20
Regulation of bcl-2 family proteins during development and in response to oxidative stress in cardiac myocytes: association with changes in mitochondrial membrane potential. Circ Res (1999) 2.18
The pharmacogenetics research network: from SNP discovery to clinical drug response. Clin Pharmacol Ther (2007) 2.18
Independence of sensitivity to relative reinforcement rate and discriminability in signal detection. J Exp Anal Behav (1980) 2.16
Randomized placebo-controlled trial of an isoflavone supplement and menopausal symptoms in women. Climacteric (1999) 2.15
19-year incidence of neural tube defects in area under constant surveillance. Lancet (1981) 2.13
The mechanism of action of capsaicin on sensory C-type neurons and their axons in vitro. Neuroscience (1987) 2.05
Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP. Am J Physiol (1994) 1.95
Stimulation of the p38 mitogen-activated protein kinase pathway in neonatal rat ventricular myocytes by the G protein-coupled receptor agonists, endothelin-1 and phenylephrine: a role in cardiac myocyte hypertrophy? J Cell Biol (1998) 1.92
On the discriminability of stimulus duration. J Exp Anal Behav (1980) 1.91
A method of preparing blood leucocytes for flow cytometry which prevents upregulation of leucocyte integrins. J Immunol Methods (1992) 1.86
Transformation of Haemophilus influenzae by plasmid RSF0885 containing a cloned segment of chromosomal deoxyribonucleic acid. J Bacteriol (1981) 1.86
Sedentary behavior during postnatal life is determined by the prenatal environment and exacerbated by postnatal hypercaloric nutrition. Am J Physiol Regul Integr Comp Physiol (2003) 1.86
Cyclic nucleotide-dependent protein kinases: intracellular receptors for cAMP and cGMP action. Crit Rev Clin Lab Sci (1999) 1.85
Genetic transformation system in the archaebacterium Methanobacterium thermoautotrophicum Marburg. J Bacteriol (1988) 1.85
Cyclic nucleotide-binding domains in proteins having diverse functions. J Biol Chem (1992) 1.82
Amino acid sequences around the sites of phosphorylation in the pig heart pyruvate dehydrogenase complex. Biochem J (1979) 1.78
Localization of enzymes and alkaloidal metabolites in Papaver latex. Arch Biochem Biophys (1983) 1.67
Nonsteroidal anti-inflammatory drugs and peptic ulcer disease. Ann Intern Med (1991) 1.67
High biochemical selectivity of tadalafil, sildenafil and vardenafil for human phosphodiesterase 5A1 (PDE5) over PDE11A4 suggests the absence of PDE11A4 cross-reaction in patients. Int J Impot Res (2005) 1.66
Rifampin is a selective, pleiotropic inducer of drug metabolism genes in human hepatocytes: studies with cDNA and oligonucleotide expression arrays. J Pharmacol Exp Ther (2001) 1.64
Isobias and alloiobias functions in animal psycophysics. J Exp Psychol Anim Behav Process (1984) 1.60
Phosphorylation of additional sites on pyruvate dehydrogenase inhibits its re-activation by pyruvate dehydrogenase phosphate phosphatase. Biochem J (1978) 1.58
Inhibition of cytochrome P450 (CYP450) isoforms by isoniazid: potent inhibition of CYP2C19 and CYP3A. Antimicrob Agents Chemother (2001) 1.58
Purification and characterization of the catalytic subunit of adenosine 3':5'-cyclic monophosphate-dependent protein kinase from bovine liver. Biochem J (1976) 1.57
Depletion of mitogen-activated protein kinase using an antisense oligodeoxynucleotide approach downregulates the phenylephrine-induced hypertrophic response in rat cardiac myocytes. Circ Res (1996) 1.57
The effects of message framing and ethnic targeting on mammography use among low-income women. Health Psychol (2001) 1.57
Towards a behavioral theory of bias in signal detection. Percept Psychophys (1981) 1.57
Delayed signal detection, differential reinforcement, and short-term memory in the pigeon. J Exp Anal Behav (1984) 1.56
Regulation of kinase reactions in pig heart pyruvate dehydrogenase complex. Biochem J (1979) 1.54
Evaluation of omeprazole and lansoprazole as inhibitors of cytochrome P450 isoforms. Drug Metab Dispos (1997) 1.52
Transformation of Haemophilus influenzae by plasmid RSF0885. J Bacteriol (1981) 1.51
The mitogen-activated protein kinase kinase MEK1 stimulates a pattern of gene expression typical of the hypertrophic phenotype in rat ventricular cardiomyocytes. J Biol Chem (1995) 1.50
Inhibition of cyclic GMP-binding cyclic GMP-specific phosphodiesterase (Type 5) by sildenafil and related compounds. Mol Pharmacol (1999) 1.50
Stimulation of intestinal Cl- transport by heat-stable enterotoxin: activation of cAMP-dependent protein kinase by cGMP. Am J Physiol (1992) 1.50
Direct evidence for cross-activation of cGMP-dependent protein kinase by cAMP in pig coronary arteries. J Biol Chem (1992) 1.49
Conversion of inactive (phosphorylated) pyruvate dehydrogenase complex into active complex by the phosphate reaction in heart mitochondria is inhibited by alloxan-diabetes or starvation in the rat. Biochem J (1978) 1.49
The interaction of stimulus and reinforcer control in complex temporal discrimination. J Exp Anal Behav (1987) 1.49
Interaction of glucocorticoids with glucagon and epinephrine in the control of gluconeogenesis and glycogenolysis in liver and of lipolysis in adipose tissue. J Biol Chem (1972) 1.49
Reinforcement for errors in a signal-detection procedure. J Exp Anal Behav (1980) 1.48
The diagnosis of iron deficiency in patients with rheumatoid arthritis and anemia: an algorithm using simple laboratory measures. J Rheumatol (1996) 1.46
Lens Opacities Classification System. Arch Ophthalmol (1988) 1.46
Cellular stresses differentially activate c-Jun N-terminal protein kinases and extracellular signal-regulated protein kinases in cultured ventricular myocytes. J Biol Chem (1995) 1.45
A SNP in steroid receptor coactivator-1 disrupts a GSK3β phosphorylation site and is associated with altered tamoxifen response in bone. Mol Endocrinol (2011) 1.45
Separation of regulatory and catalytic subunits of the cyclic 3',5'-adenosine monophosphate-dependent protein kinase(s) of rabbit skeletal muscle. Biochem Biophys Res Commun (1971) 1.44
Predicted structures of the cGMP binding domains of the cGMP-dependent protein kinase: a key alanine/threonine difference in evolutionary divergence of cAMP and cGMP binding sites. Biochemistry (1989) 1.43
Closing volume in asymptomatic asthma. Am Rev Respir Dis (1973) 1.43
Cytochrome P450 2D6 activity predicts discontinuation of tamoxifen therapy in breast cancer patients. Pharmacogenomics J (2009) 1.43
Interaction of the subunits of adenosine 3':5'-cyclic monophosphate-dependent protein kinase of muscle. Proc Natl Acad Sci U S A (1971) 1.42
Regulation of intracellular Ca2+ levels in cultured vascular smooth muscle cells. Reduction of Ca2+ by atriopeptin and 8-bromo-cyclic GMP is mediated by cyclic GMP-dependent protein kinase. J Biol Chem (1989) 1.42
KT5823 inhibits cGMP-dependent protein kinase activity in vitro but not in intact human platelets and rat mesangial cells. J Biol Chem (2000) 1.41
Intrinsically stable IgG aggregates. J Immunol Methods (1981) 1.41
On the question of translocation of heart cAMP-dependent protein kinase. Proc Natl Acad Sci U S A (1975) 1.41
Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants. Pharmacogenetics (2001) 1.39
Estrogen receptor genotypes, menopausal status, and the lipid effects of tamoxifen. Clin Pharmacol Ther (2007) 1.39
Regulation of adenosine 3',5'-monophosphate-dependent protein kinase. I. Preliminary characterization of the adipose tissue enzyme in crude extracts. J Biol Chem (1973) 1.38
Infusion of vincristine and doxorubicin with oral dexamethasone as first-line therapy for multiple myeloma. Lancet (1989) 1.38
Delayed matching-to-sample performance: Effects of relative reinforcer frequency and of signaled versus unsignaled reinforcer magnitudes. J Exp Anal Behav (1995) 1.37
ANF elicits phosphorylation of the cGMP phosphodiesterase in vascular smooth muscle cells. Am J Physiol (1998) 1.37
Activation of adipose tissue lipase by skeletal muscle cyclic adenosine 3',5'- monophosphate-stimulated protein kinase. J Biol Chem (1970) 1.36
The structure of a bovine lung cGMP-binding, cGMP-specific phosphodiesterase deduced from a cDNA clone. J Biol Chem (1993) 1.35
A plasmid cloning vehicle for Haemophilus influenzae and Escherichia coli. J Bacteriol (1982) 1.35
The star-allele nomenclature: retooling for translational genomics. Clin Pharmacol Ther (2007) 1.35
Independence of stimulus discriminability from absolute rate of reinforcement in a signal-detection procedure. J Exp Anal Behav (1982) 1.35
Relaxation of vascular and tracheal smooth muscle by cyclic nucleotide analogs that preferentially activate purified cGMP-dependent protein kinase. Mol Pharmacol (1988) 1.33
Regulation of sarcoplasmic reticulum protein phosphorylation by localized cyclic GMP-dependent protein kinase in vascular smooth muscle cells. Mol Pharmacol (1991) 1.33
Allelic, genotypic and phenotypic distributions of S-mephenytoin 4'-hydroxylase (CYP2C19) in healthy Caucasian populations of European descent throughout the world. Pharmacogenetics (1999) 1.33
Cyclic GMP-dependent protein kinase regulates vascular smooth muscle cell phenotype. J Vasc Res (1997) 1.32
Phosphorylation of mammalian myosin light chain kinases by the catalytic subunit of cyclic AMP-dependent protein kinase and by cyclic GMP-dependent protein kinase. J Biol Chem (1984) 1.32
The hydroxylation of omeprazole correlates with S-mephenytoin metabolism: a population study. Clin Pharmacol Ther (1995) 1.31
Potassium channel stimulation by natriuretic peptides through cGMP-dependent dephosphorylation. Nature (1993) 1.31
Activation of c-Jun N-terminal kinases and p38-mitogen-activated protein kinases in human heart failure secondary to ischaemic heart disease. J Mol Cell Cardiol (1999) 1.31
Phosphorylation of the inositol 1,4,5-trisphosphate receptor by cyclic GMP-dependent protein kinase. J Biol Chem (1994) 1.29
Duchenne muscular dystrophy in one of monozygotic twin girls. J Med Genet (1986) 1.28
The p38-MAPK inhibitor, SB203580, inhibits cardiac stress-activated protein kinases/c-Jun N-terminal kinases (SAPKs/JNKs). FEBS Lett (1998) 1.28
Regulation of pig heart pyruvate dehydrogenase by phosphorylation. Studies on the subunit and phosphorylation stoicheiometries. Biochem J (1978) 1.26
The effects of glucose, acetate, lactate and insulin on protein degradation in the perfused rat heart. Biochem J (1982) 1.26